| Literature DB >> 33670477 |
Carla de Sanctis Pecora1, Danielle Shitara1.
Abstract
Unilateral peripheral facial nerve palsy jeopardizes quality of life, rendering psychological consequences such as low self-esteem, social isolation, anxiety, and depression. Among therapeutical approaches, use of Botulinum toxin type A (BoNT-A) on the nonparalyzed side has shown promising results and improvement of quality of life. Nevertheless, the correct technique is paramount, since over-injection of the muscles can result in lack of function, leading to a "paralyzed" appearance, and even worse, functional incompetence, which may cause greater distress to patients. Therefore, the objective of this article is to provide a practical guideline for botulinum toxin use in facial palsy. To this aim, adequate patient assessment, BoNT-A choice, injection plan and dosage, and injection techniques are covered.Entities:
Keywords: botulinum toxin A; facial asymmetry; facial palsy; facial paralysis; incobotulinum-toxin A; neurotoxin
Mesh:
Substances:
Year: 2021 PMID: 33670477 PMCID: PMC7923088 DOI: 10.3390/toxins13020159
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546